These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31031710)

  • 1. Association of
    Son KA; Lee DY; Choi D
    Front Endocrinol (Lausanne); 2019; 10():235. PubMed ID: 31031710
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?
    van Tilborg TC; Derks-Smeets IA; Bos AM; Oosterwijk JC; van Golde RJ; de Die-Smulders CE; van der Kolk LE; van Zelst-Stams WA; Velthuizen ME; Hoek A; Eijkemans MJ; Laven JS; Ausems MG; Broekmans FJ
    Hum Reprod; 2016 Nov; 31(11):2651-2659. PubMed ID: 27907901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
    Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
    Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 germline mutations may be associated with reduced ovarian reserve.
    Wang ET; Pisarska MD; Bresee C; Chen YD; Lester J; Afshar Y; Alexander C; Karlan BY
    Fertil Steril; 2014 Dec; 102(6):1723-8. PubMed ID: 25256924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimüllerian hormone levels are lower in BRCA2 mutation carriers.
    Johnson L; Sammel MD; Domchek S; Schanne A; Prewitt M; Gracia C
    Fertil Steril; 2017 May; 107(5):1256-1265.e6. PubMed ID: 28476184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer Risk.
    Giordano S; Garrett-Mayer E; Mittal N; Smith K; Shulman L; Passaglia C; Gradishar W; Pavone ME
    J Adolesc Young Adult Oncol; 2016 Dec; 5(4):337-343. PubMed ID: 27513691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of ovarian reserve and reproductive outcomes in
    Ponce J; Fernandez-Gonzalez S; Calvo I; Climent M; Peñafiel J; Feliubadaló L; Teulé A; Lázaro C; Brunet JM; Candás-Estébanez B; Durán Retamal M
    Int J Gynecol Cancer; 2020 Jan; 30(1):83-88. PubMed ID: 31780568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status.
    C E DK; C VTT; J C EM; G W M LE; Irene H; Mariette G; J T VGR; Willem V; D LK; J M BF; M E BA
    Reprod Sci; 2023 Jan; 30(1):270-282. PubMed ID: 35705781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA mutation carriers do not have compromised ovarian reserve.
    Michaelson-Cohen R; Mor P; Srebnik N; Beller U; Levy-Lahad E; Eldar-Geva T
    Int J Gynecol Cancer; 2014 Feb; 24(2):233-7. PubMed ID: 24378620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.
    Lambertini M; Goldrat O; Ferreira AR; Dechene J; Azim HA; Desir J; Delbaere A; t'Kint de Roodenbeke MD; de Azambuja E; Ignatiadis M; Demeestere I
    Ann Oncol; 2018 Jan; 29(1):237-243. PubMed ID: 29045555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of BRCA mutations and hormone receptor status on reproductive potential in breast cancer patients undergoing fertility preservation.
    Kim SW; Kim TH; Han JY; Kim SK; Lee JR; Jee UC; Suh CS; Kim SH
    Gynecol Endocrinol; 2022 Mar; 38(3):227-230. PubMed ID: 34775902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Taxanes, Endocrine Therapy, and Deleterious Germline
    Lambertini M; Olympios N; Lequesne J; Calbrix C; Fontanilles M; Loeb A; Leheurteur M; Demeestere I; Di Fiore F; Perdrix A; Clatot F
    Front Oncol; 2019; 9():575. PubMed ID: 31355134
    [No Abstract]   [Full Text] [Related]  

  • 14. BRCA1/2 genes mutations, ovarian reserve and female reproductive outcomes: a systematic review of the literature.
    Merlino L; Chiné A; Galli C; Piccioni MG
    Minerva Ginecol; 2020 Oct; 72(5):339-348. PubMed ID: 32744451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis.
    Gasparri ML; Di Micco R; Zuber V; Taghavi K; Bianchini G; Bellaminutti S; Meani F; Graffeo R; Candiani M; Mueller MD; Papadia A; Gentilini OD
    Breast; 2021 Dec; 60():155-162. PubMed ID: 34627117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of BRCA gene mutation on female reproductive potential: A systematic review.
    Hu KL; Wang S; Ye X; Zhang D
    Maturitas; 2020 Jul; 137():11-17. PubMed ID: 32498931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk.
    Kwiatkowski F; Arbre M; Bidet Y; Laquet C; Uhrhammer N; Bignon YJ
    PLoS One; 2015; 10(6):e0127363. PubMed ID: 26047126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
    Wang YA; Jian JW; Hung CF; Peng HP; Yang CF; Cheng HS; Yang AS
    BMC Cancer; 2018 Mar; 18(1):315. PubMed ID: 29566657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation.
    Vicus D; Finch A; Rosen B; Fan I; Bradley L; Cass I; Sun P; Karlan B; McLaughlin J; Narod SA;
    Gynecol Oncol; 2010 Aug; 118(2):155-9. PubMed ID: 20452659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premature ovarian aging in
    Ben-Aharon I; Levi M; Margel D; Yerushalmi R; Rizel S; Perry S; Sharon E; Hasky N; Abir R; Fisch B; Tobar A; Shalgi R; Stemmer SM
    Oncotarget; 2018 Mar; 9(22):15931-15941. PubMed ID: 29662617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.